{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T16:53:17Z","timestamp":1770828797099,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nefrolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.nefroe.2024.12.002","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T12:30:30Z","timestamp":1736512230000},"page":"1-4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Some thoughts about the \u201cConsensus statement on smoking and vascular risk\u201d from the Spanish Autonomous Societies of Hypertension and Vascular Risk"],"prefix":"10.1016","volume":"45","author":[{"given":"Javier","family":"Nieto Iglesias","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso Pobes","family":"Mart\u00ednez de Salinas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicol\u00e1s Roberto Robles","family":"P\u00e9rez-Monteoliva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefroe.2024.12.002_bib0005","unstructured":"Adaptaci\u00f3n Espa\u00f1ola de las gu\u00edas europeas sobre prevenci\u00f3n de la enfermedad vascular en la pr\u00e1ctica cl\u00ednica. Comit\u00e9 Espa\u00f1ol Interdisciplinario para la Prevenci\u00f3n Vascular. A\u00f1o 2022. Available from: https:\/\/www.aepap.org\/sites\/default\/files\/documento\/archivosadjuntos\/guia_vascular_corregida.pdf Accedido el 30 de abril de 2024."},{"key":"10.1016\/j.nefroe.2024.12.002_bib0010","unstructured":"Encuesta de Salud de la Fundaci\u00f3n Espa\u00f1ola del Coraz\u00f3n. Available from: https:\/\/fundaciondelcorazon.com\/corazon-facil\/recursos-didacticos\/informes.html Accedido el 30 de abril de 2024."},{"key":"10.1016\/j.nefroe.2024.12.002_bib0015","unstructured":"Encuesta sobre Alcohol y Otras Drogas en Espa\u00f1a (EDADES), 1995-2022. Delegaci\u00f3n del Gobierno para el Plan Nacional sobre Drogas. Secretar\u00eda General de Sanidad. Ministerio de Sanidad. Available from: https:\/\/pnsd.sanidad.gob.es\/profesionales\/sistemasInformacion\/sistemaInformacion\/pdf\/2022_Informe_EDADES.pdf Accedido el 30 de abril de 2024."},{"key":"10.1016\/j.nefroe.2024.12.002_bib0020","unstructured":"Encuesta sobre Uso de Drogas en Ense\u00f1anzas Secundarias en Espa\u00f1a (ESTUDES), 1994-2023. Delegaci\u00f3n del Gobierno para el Plan Nacional sobre Drogas. Secretar\u00eda General de Sanidad. Ministerio Sanidad. Available from: https:\/\/pnsd.sanidad.gob.es\/profesionales\/sistemasInformacion\/sistemaInformacion\/pdf\/ESTUDES_2023_Informe.pdf Accedido el 30 de abril de 2024."},{"key":"10.1016\/j.nefroe.2024.12.002_bib0025","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000517749","article-title":"Smoking and kidney disease: risk factors, challenges and preventive strategies","volume":"199","author":"Oliveira Coelho","year":"2021","journal-title":"Contrib Nephrol."},{"key":"10.1016\/j.nefroe.2024.12.002_bib0030","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/ndt\/gfw448","article-title":"Smoking and chronic kidney disease: seeing the signs through the smoke?","volume":"32","author":"Van Laecke","year":"2017","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefroe.2024.12.002_bib0035","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/ndt\/gfw452","article-title":"Cigarette smoking and chronic kidney disease in the general population: a systematic review and meta-analysis of prospective cohort studies","volume":"32","author":"Xia","year":"2017","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefroe.2024.12.002_bib0040","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1681\/ASN.2020030384","article-title":"Modifiable lifestyle factors for primary prevention of CKD: a systematic review and meta-analysis","volume":"32","author":"Kelly","year":"2021","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nefroe.2024.12.002_bib0045","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/ki.2011.157","article-title":"Smoking is a risk factor in the progression to kidney failure","volume":"80","author":"Hallan","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefroe.2024.12.002_bib0050","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1096\/fj.12-206458","article-title":"General mechanisms of nicotine-induced fibrogenesis","volume":"26","author":"Jensen","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.nefroe.2024.12.002_bib0055","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/MNH.0000000000000062","article-title":"Advanced glycation end product accumulation: a new enemy to target in chronic kidney disease?","volume":"23","author":"Mallipattu","year":"2014","journal-title":"Curr Opin Nephrol Hypertens."},{"key":"10.1016\/j.nefroe.2024.12.002_bib0060","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1097\/01.ASN.0000018401.82863.FD","article-title":"Smoking and the kidney","volume":"13","author":"Orth","year":"2002","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nefroe.2024.12.002_bib0065","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.hipert.2021.04.001","article-title":"Update on smoking. Alternatives for the management of patients with cardiovascular risk","volume":"38","author":"Nieto Iglesias","year":"2021","journal-title":"Hipertens Riesgo Vasc"},{"key":"10.1016\/j.nefroe.2024.12.002_bib0070","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1161\/CIRCGENETICS.116.001506","article-title":"Epigenetic signatures of cigarette smoking","volume":"9","author":"Joehanes","year":"2016","journal-title":"Circ Cardiovasc Genet."},{"key":"10.1016\/j.nefroe.2024.12.002_bib0075","doi-asserted-by":"crossref","first-page":"F732","DOI":"10.1152\/ajprenal.00293.2010","article-title":"Nicotine worsens the severity of nephropathy in diabetic mice: implications for the progression of kidney diseases in smokers","volume":"299","author":"Hua","year":"2010","journal-title":"Am J Physiol Renal Physiol."},{"issue":"8","key":"10.1016\/j.nefroe.2024.12.002_bib0080","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1053\/hupa.2002.126189","article-title":"Idiopathic nodular glomerulosclerosis is a distinct clinico-pathologic entity linked to hypertension and smoking","volume":"33","author":"Markowitz","year":"2002","journal-title":"Hum Pathol."},{"issue":"2917","key":"10.1016\/j.nefroe.2024.12.002_bib0085","article-title":"Diabetic proteinuria revisited: updated physiologic perspectives","volume":"11","author":"Heyman","year":"2022","journal-title":"Cells."},{"key":"10.1016\/j.nefroe.2024.12.002_bib0090","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1523-1755.2003.00712.x","article-title":"Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64)","volume":"63","author":"Adler","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefroe.2024.12.002_bib0095","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1157\/13116172","article-title":"Riesgo cardiovascular asociado a microalbuminuria en pacientes diab\u00e9ticos y en pacientes con hipertensi\u00f3n arterial [Microalbuminuria-related cardiovascular risk in diabetic patients and hypertensive (non-diabetic) population]","volume":"130","author":"Robles","year":"2008","journal-title":"Med Clin (Barc)."},{"key":"10.1016\/j.nefroe.2024.12.002_bib0100","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jama.286.4.421","article-title":"Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals","volume":"286","author":"Gerstein","year":"2001","journal-title":"JAMA."},{"key":"10.1016\/j.nefroe.2024.12.002_bib0105","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/01.CIR.0000031732.78052.81","article-title":"Urinary albumin excretion predicts cardiovascular and non-cardiovascular mortality in general population","volume":"106","author":"Hillege","year":"2002","journal-title":"Circulation."},{"key":"10.1016\/j.nefroe.2024.12.002_bib0110","article-title":"Predictors and determinants of albuminuria in people with prediabetes and diabetes based on smoking status: a cross-sectional study using the UK Biobank data","volume":"51","author":"Kar","year":"2022","journal-title":"E Clin Med."},{"key":"10.1016\/j.nefroe.2024.12.002_bib0115","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s11255-018-1825-x","article-title":"Cigarette smoking and risk of albuminuria in patients with type 2 diabetes: a systematic review and meta-analysis of observational studies","volume":"50","author":"Xu","year":"2018","journal-title":"Int Urol Nephrol."},{"key":"10.1016\/j.nefroe.2024.12.002_bib0120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000498830","article-title":"Increased microalbuminuria risk in male cigarette smokers: results from the \"Olivetti Heart Study\" after 8 years follow-up","volume":"44","author":"Barbato","year":"2019","journal-title":"Kidney Blood Press Res."},{"issue":"2","key":"10.1016\/j.nefroe.2024.12.002_bib0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246017","article-title":"Association between cotinine-verified smoking status and moderately increased albuminuria in the middle-aged and older population in Korea: a nationwide population-based study","volume":"16","author":"Choi","year":"2021","journal-title":"PLoS One."},{"key":"10.1016\/j.nefroe.2024.12.002_bib0130","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4103\/0971-4065.127893","article-title":"Impact of smoking on microalbuminuria and urinary albumin creatinine ratio in non-diabetic normotensive smokers","volume":"24","author":"Gupta","year":"2014","journal-title":"Indian J Nephrol"},{"key":"10.1016\/j.nefroe.2024.12.002_bib0135","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.2215\/CJN.00700111","article-title":"Cigarette smoking and the association with glomerular hyperfiltration and proteinuria in healthy middle-aged men","volume":"6","author":"Maeda","year":"2011","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.nefroe.2024.12.002_bib0140","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/hr.2010.154","article-title":"C-reactive protein is associated with cigarette smokig-induced hyperfiltration and proteinuria in an apparently healthy population","volume":"33","author":"Sauriasari","year":"2010","journal-title":"Hypetens Res."},{"key":"10.1016\/j.nefroe.2024.12.002_bib0145","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000481206","article-title":"Cigarette smoking attenuates kidney protection by angiotensin-converting enzyme inhibition in nondiabetic chronic kidney disease","volume":"46","author":"Roehm","year":"2017","journal-title":"Am J Nephrol."},{"issue":"Supl 1","key":"10.1016\/j.nefroe.2024.12.002_bib0150","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1889-1837(24)00075-8","article-title":"Documento de consenso sobre tabaquismo y riesgo vascular","volume":"4","author":"Abell\u00e1n Alem\u00e1n","year":"2024","journal-title":"Hipertens Riesgo Vasc."}],"container-title":["Nefrolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2013251424002360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2013251424002360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T00:34:25Z","timestamp":1744504465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2013251424002360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2013251424002360"],"URL":"https:\/\/doi.org\/10.1016\/j.nefroe.2024.12.002","relation":{},"ISSN":["2013-2514"],"issn-type":[{"value":"2013-2514","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Some thoughts about the \u201cConsensus statement on smoking and vascular risk\u201d from the Spanish Autonomous Societies of Hypertension and Vascular Risk","name":"articletitle","label":"Article Title"},{"value":"Nefrolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nefroe.2024.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.nefro.2024.09.001","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Sociedad Espa\u00f1ola de Nefrolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}